A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
Cyteir Therapeutics, Inc.
Cyteir Therapeutics, Inc.
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
Barbara Ann Karmanos Cancer Institute
Rutgers, The State University of New Jersey
National Institutes of Health Clinical Center (CC)